Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Chimerix, Inc. (CMRX) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Chimerix, Inc. (CMRX) lobbying for?
Summary of lobbying data:
– Lobbying firms: Baker Donelson Bearman Caldwell & Berkowitz /The Daschle Group
– General issues: Health Issues
– Specific issues: Funding and issues related to U.S. monkeypox response, provisions related to drug PRVs, H.R. 4439 and Cosmetic Act with respect to the scope of new chemical exclusivity, funding for Public Health and Social Services Emergency Fund, issues related to U.S. smallpox and monkeypox response, MCM development & procurement process, stockpiling, provisions related to drug PRVs, FY2021 Omnibus and COVID Relief and Response Act, Lower Health Care Costs Act, Creating Hope Reauthorization Act, S. 415, Medical countermeasure development and procurement, and Drug.
– Government agencies: Senate, Executive Office of the President (EOP), House of Representatives
One could infer that Chimerix, Inc. is lobbying on health issues related to funding and the development and procurement of medical countermeasures (MCMs), particularly with regards to the response to infectious diseases such as monkeypox and smallpox. They are also focused on issues related to drug PRVs (priority review vouchers) and exclusivity provisions. The company may be seeking to influence government policies and funding decisions in order to advance their own interests and support the development of their products, which are primarily focused on antiviral therapies.
